Alterity Therapeutics (PRNAD) Change in Accured Expenses (2009 - 2020)

Alterity Therapeutics (PRNAD) has reported Change in Accured Expenses for 10 consecutive years, with $10868.2 the latest figure, recorded in Q2 2020.

• In Q2 2020, Change in Accured Expenses fell 67.24% year-over-year to $10868.2; the TTM figure through Jun 2020 stood at $23360.8 (down 84.05% YoY), while the FY2020 annual figure was $11133.2, down 67.15% from the prior year.
• Change in Accured Expenses came in at $10868.2 for Q2 2020 at Alterity Therapeutics, up from -$48058.2 in the prior quarter.
• The five-year high for Change in Accured Expenses was $86708.3 in Q4 2017, with the low at -$48058.2 in Q4 2019.
• Average Change in Accured Expenses over 5 years is $20907.9, with a median of $19121.7 recorded in 2018.
• The largest YoY upside for Change in Accured Expenses was 4125.31% in 2019 against a maximum downside of 275.55% in 2019.
• Year by year, Change in Accured Expenses stood at -$9017.2 in 2016, then jumped by 1061.59% to $86708.3 in 2017, then plunged by 68.43% to $27375.1 in 2018, then tumbled by 275.55% to -$48058.2 in 2019, then soared by 122.61% to $10868.2 in 2020.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered $10868.2, -$48058.2, and $33175.8 for Q2 2020, Q4 2019, and Q2 2019 respectively.